MedPath
NMPA Approval

Olmesartan Medoxomil Tablets

国药准字H20243307

March 5, 2024

Drug Information

奥美沙坦酯片

片剂

40mg

化学药品

March 5, 2024

Company Information

Applicant Company

长春市高新开发区北区北远达大街7988号

Manufacturing Company

长春市高新开发区北区北远达大街7988号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯片 - NMPA 批准文号 | MedPath